ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Allergy Immunotherapies Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-18Y14315
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Subcutaneous Allergy Immunotherapies Market Research Report 2023
BUY CHAPTERS

Global Subcutaneous Allergy Immunotherapies Market Research Report 2025

Code: QYRE-Auto-18Y14315
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ALK Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

Subcutaneous Allergy Immunotherapies Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Subcutaneous Allergy Immunotherapies Market

Subcutaneous Allergy Immunotherapies Market

The global market for Subcutaneous Allergy Immunotherapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Allergy Immunotherapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Allergy Immunotherapies.
The Subcutaneous Allergy Immunotherapies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Allergy Immunotherapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Allergy Immunotherapies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Subcutaneous Allergy Immunotherapies Market Report

Report Metric Details
Report Name Subcutaneous Allergy Immunotherapies Market
CAGR 5%
Segment by Type
  • High Concentration
  • Low Concentration
Segment by Application
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Subcutaneous Allergy Immunotherapies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Subcutaneous Allergy Immunotherapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Subcutaneous Allergy Immunotherapies Market report?

Ans: The main players in the Subcutaneous Allergy Immunotherapies Market are ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti

What are the Application segmentation covered in the Subcutaneous Allergy Immunotherapies Market report?

Ans: The Applications covered in the Subcutaneous Allergy Immunotherapies Market report are Primary Immunodeficiency, Secondary Immunodeficiency, Others

What are the Type segmentation covered in the Subcutaneous Allergy Immunotherapies Market report?

Ans: The Types covered in the Subcutaneous Allergy Immunotherapies Market report are High Concentration, Low Concentration

Recommended Reports

Allergy Therapeutics

Immunotherapy Markets

Allergic Rhinitis Drugs

1 Subcutaneous Allergy Immunotherapies Market Overview
1.1 Product Definition
1.2 Subcutaneous Allergy Immunotherapies by Type
1.2.1 Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Type (2024 VS 2031)
1.2.2 High Concentration
1.2.3 Low Concentration
1.3 Subcutaneous Allergy Immunotherapies by Application
1.3.1 Global Subcutaneous Allergy Immunotherapies Market Value by Application (2024 VS 2031)
1.3.2 Primary Immunodeficiency
1.3.3 Secondary Immunodeficiency
1.3.4 Others
1.4 Global Subcutaneous Allergy Immunotherapies Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Allergy Immunotherapies Revenue 2020-2031
1.4.2 Global Subcutaneous Allergy Immunotherapies Sales 2020-2031
1.4.3 Global Subcutaneous Allergy Immunotherapies Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Subcutaneous Allergy Immunotherapies Market Competition by Manufacturers
2.1 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Allergy Immunotherapies Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Allergy Immunotherapies, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Date of Enter into This Industry
2.8 Global Subcutaneous Allergy Immunotherapies Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Allergy Immunotherapies Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Allergy Immunotherapies Players Market Share by Revenue
2.8.3 Global Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Allergy Immunotherapies Market Scenario by Region
3.1 Global Subcutaneous Allergy Immunotherapies Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Allergy Immunotherapies Sales by Region: 2026-2031
3.3 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Allergy Immunotherapies Revenue by Region: 2026-2031
3.4 North America Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.4.1 North America Subcutaneous Allergy Immunotherapies Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Allergy Immunotherapies Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Allergy Immunotherapies Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Allergy Immunotherapies Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Allergy Immunotherapies Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Allergy Immunotherapies Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Allergy Immunotherapies Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Allergy Immunotherapies Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Allergy Immunotherapies Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Allergy Immunotherapies Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Allergy Immunotherapies Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Allergy Immunotherapies Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Allergy Immunotherapies Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Allergy Immunotherapies Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Allergy Immunotherapies Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Allergy Immunotherapies Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ALK-Abello
6.1.1 ALK-Abello Company Information
6.1.2 ALK-Abello Description and Business Overview
6.1.3 ALK-Abello Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ALK-Abello Subcutaneous Allergy Immunotherapies Product Portfolio
6.1.5 ALK-Abello Recent Developments/Updates
6.2 Stallergenes Greer
6.2.1 Stallergenes Greer Company Information
6.2.2 Stallergenes Greer Description and Business Overview
6.2.3 Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Stallergenes Greer Subcutaneous Allergy Immunotherapies Product Portfolio
6.2.5 Stallergenes Greer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Subcutaneous Allergy Immunotherapies Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Allergy Therapeutics
6.4.1 Allergy Therapeutics Company Information
6.4.2 Allergy Therapeutics Description and Business Overview
6.4.3 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product Portfolio
6.4.5 Allergy Therapeutics Recent Developments/Updates
6.5 HAL
6.5.1 HAL Company Information
6.5.2 HAL Description and Business Overview
6.5.3 HAL Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.5.4 HAL Subcutaneous Allergy Immunotherapies Product Portfolio
6.5.5 HAL Recent Developments/Updates
6.6 WOLW Pharma
6.6.1 WOLW Pharma Company Information
6.6.2 WOLW Pharma Description and Business Overview
6.6.3 WOLW Pharma Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.6.4 WOLW Pharma Subcutaneous Allergy Immunotherapies Product Portfolio
6.6.5 WOLW Pharma Recent Developments/Updates
6.7 Holister Stier
6.7.1 Holister Stier Company Information
6.7.2 Holister Stier Description and Business Overview
6.7.3 Holister Stier Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Holister Stier Subcutaneous Allergy Immunotherapies Product Portfolio
6.7.5 Holister Stier Recent Developments/Updates
6.8 Leti
6.8.1 Leti Company Information
6.8.2 Leti Description and Business Overview
6.8.3 Leti Subcutaneous Allergy Immunotherapies Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Leti Subcutaneous Allergy Immunotherapies Product Portfolio
6.8.5 Leti Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Allergy Immunotherapies Industry Chain Analysis
7.2 Subcutaneous Allergy Immunotherapies Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Allergy Immunotherapies Production Mode & Process Analysis
7.4 Subcutaneous Allergy Immunotherapies Sales and Marketing
7.4.1 Subcutaneous Allergy Immunotherapies Sales Channels
7.4.2 Subcutaneous Allergy Immunotherapies Distributors
7.5 Subcutaneous Allergy Immunotherapies Customer Analysis
8 Subcutaneous Allergy Immunotherapies Market Dynamics
8.1 Subcutaneous Allergy Immunotherapies Industry Trends
8.2 Subcutaneous Allergy Immunotherapies Market Drivers
8.3 Subcutaneous Allergy Immunotherapies Market Challenges
8.4 Subcutaneous Allergy Immunotherapies Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ALK Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti
List of Tables
 Table 1. Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Subcutaneous Allergy Immunotherapies Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Subcutaneous Allergy Immunotherapies Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Subcutaneous Allergy Immunotherapies Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Subcutaneous Allergy Immunotherapies Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Subcutaneous Allergy Immunotherapies Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Subcutaneous Allergy Immunotherapies, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Product Type & Application
 Table 12. Global Key Manufacturers of Subcutaneous Allergy Immunotherapies, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Subcutaneous Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Allergy Immunotherapies as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Subcutaneous Allergy Immunotherapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Subcutaneous Allergy Immunotherapies Sales by Region (2020-2025) & (K Units)
 Table 18. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2020-2025)
 Table 19. Global Subcutaneous Allergy Immunotherapies Sales by Region (2026-2031) & (K Units)
 Table 20. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2026-2031)
 Table 21. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2020-2025)
 Table 23. Global Subcutaneous Allergy Immunotherapies Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2026-2031)
 Table 25. North America Subcutaneous Allergy Immunotherapies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Subcutaneous Allergy Immunotherapies Sales by Country (2020-2025) & (K Units)
 Table 27. North America Subcutaneous Allergy Immunotherapies Sales by Country (2026-2031) & (K Units)
 Table 28. North America Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Subcutaneous Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Subcutaneous Allergy Immunotherapies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Subcutaneous Allergy Immunotherapies Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Subcutaneous Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Subcutaneous Allergy Immunotherapies Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Subcutaneous Allergy Immunotherapies Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Type (2020-2025)
 Table 51. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Type (2026-2031)
 Table 52. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2020-2025)
 Table 53. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Type (2026-2031)
 Table 54. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2020-2025)
 Table 57. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Type (2026-2031)
 Table 58. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Application (2020-2025)
 Table 61. Global Subcutaneous Allergy Immunotherapies Sales (K Units) by Application (2026-2031)
 Table 62. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2020-2025)
 Table 63. Global Subcutaneous Allergy Immunotherapies Sales Market Share by Application (2026-2031)
 Table 64. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Subcutaneous Allergy Immunotherapies Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2020-2025)
 Table 67. Global Subcutaneous Allergy Immunotherapies Revenue Market Share by Application (2026-2031)
 Table 68. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Application (2026-2031)
 Table 70. ALK-Abello Company Information
 Table 71. ALK-Abello Description and Business Overview
 Table 72. ALK-Abello Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. ALK-Abello Subcutaneous Allergy Immunotherapies Product
 Table 74. ALK-Abello Recent Developments/Updates
 Table 75. Stallergenes Greer Company Information
 Table 76. Stallergenes Greer Description and Business Overview
 Table 77. Stallergenes Greer Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Stallergenes Greer Subcutaneous Allergy Immunotherapies Product
 Table 79. Stallergenes Greer Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Subcutaneous Allergy Immunotherapies Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Allergy Therapeutics Company Information
 Table 86. Allergy Therapeutics Description and Business Overview
 Table 87. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Allergy Therapeutics Subcutaneous Allergy Immunotherapies Product
 Table 89. Allergy Therapeutics Recent Developments/Updates
 Table 90. HAL Company Information
 Table 91. HAL Description and Business Overview
 Table 92. HAL Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. HAL Subcutaneous Allergy Immunotherapies Product
 Table 94. HAL Recent Developments/Updates
 Table 95. WOLW Pharma Company Information
 Table 96. WOLW Pharma Description and Business Overview
 Table 97. WOLW Pharma Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. WOLW Pharma Subcutaneous Allergy Immunotherapies Product
 Table 99. WOLW Pharma Recent Developments/Updates
 Table 100. Holister Stier Company Information
 Table 101. Holister Stier Description and Business Overview
 Table 102. Holister Stier Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Holister Stier Subcutaneous Allergy Immunotherapies Product
 Table 104. Holister Stier Recent Developments/Updates
 Table 105. Leti Company Information
 Table 106. Leti Description and Business Overview
 Table 107. Leti Subcutaneous Allergy Immunotherapies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Leti Subcutaneous Allergy Immunotherapies Product
 Table 109. Leti Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Subcutaneous Allergy Immunotherapies Distributors List
 Table 113. Subcutaneous Allergy Immunotherapies Customers List
 Table 114. Subcutaneous Allergy Immunotherapies Market Trends
 Table 115. Subcutaneous Allergy Immunotherapies Market Drivers
 Table 116. Subcutaneous Allergy Immunotherapies Market Challenges
 Table 117. Subcutaneous Allergy Immunotherapies Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Subcutaneous Allergy Immunotherapies
 Figure 2. Global Subcutaneous Allergy Immunotherapies Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Allergy Immunotherapies Market Share by Type: 2024 & 2031
 Figure 4. High Concentration Product Picture
 Figure 5. Low Concentration Product Picture
 Figure 6. Global Subcutaneous Allergy Immunotherapies Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Subcutaneous Allergy Immunotherapies Market Share by Application: 2024 & 2031
 Figure 8. Primary Immunodeficiency
 Figure 9. Secondary Immunodeficiency
 Figure 10. Others
 Figure 11. Global Subcutaneous Allergy Immunotherapies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Subcutaneous Allergy Immunotherapies Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Subcutaneous Allergy Immunotherapies Sales (2020-2031) & (K Units)
 Figure 14. Global Subcutaneous Allergy Immunotherapies Average Price (US$/Unit) & (2020-2031)
 Figure 15. Subcutaneous Allergy Immunotherapies Report Years Considered
 Figure 16. Subcutaneous Allergy Immunotherapies Sales Share by Manufacturers in 2024
 Figure 17. Global Subcutaneous Allergy Immunotherapies Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Subcutaneous Allergy Immunotherapies Players: Market Share by Revenue in Subcutaneous Allergy Immunotherapies in 2024
 Figure 19. Subcutaneous Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Subcutaneous Allergy Immunotherapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2020-2031)
 Figure 22. North America Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
 Figure 23. United States Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2020-2031)
 Figure 26. Europe Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Subcutaneous Allergy Immunotherapies Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Subcutaneous Allergy Immunotherapies Revenue Market Share by Region (2020-2031)
 Figure 34. China Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Subcutaneous Allergy Immunotherapies Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Subcutaneous Allergy Immunotherapies Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Subcutaneous Allergy Immunotherapies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Subcutaneous Allergy Immunotherapies by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Subcutaneous Allergy Immunotherapies by Type (2020-2031)
 Figure 55. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Subcutaneous Allergy Immunotherapies by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Subcutaneous Allergy Immunotherapies by Application (2020-2031)
 Figure 58. Global Subcutaneous Allergy Immunotherapies Price (US$/Unit) by Application (2020-2031)
 Figure 59. Subcutaneous Allergy Immunotherapies Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Sublingual Allergy Immunotherapy Market Research Report 2024
Global Subcutaneous Immunotherapy Market Research Report 2024
Global Allergy Immunotherapies Market Research Report 2025
Global Sublingual Immunotherapy Market Research Report 2024
Desensitization Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Allergy Desensitization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Desensitization Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Desensitization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyposensitization Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hypo sensitization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyposensitization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Subcutaneous Vaccine Adjuvants Market Research Report 2025
Global Skin Allergy Treatment Market Insights Forecast to 2030
Global Seafood Allergy Treatment Market Research Report 2024
Global Food Allergy Immunotherapies Market Research Report 2024
Mugwort Pollen and Allergies Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune System Allergy Treatment Market Research Report 2025
Immune Globulin Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Food Allergy Treatment Market Research Report 2024
Birch Allergy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions